Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Resistance in Multiple System Atrophy
NCT04250493Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Oct 2020
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Homeostasis Model Assessment of Insulin Resistance Index at Day 0. Started Oct 2020; status: recruiting.
Beyond the preview
Go deeper on NCT04250493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04250493.